annual net income:
$73.86M+$72.55M(+5512.84%)Summary
- As of today (May 29, 2025), SUPN annual net profit is $73.86 million, with the most recent change of +$72.55 million (+5512.84%) on December 31, 2024.
- During the last 3 years, SUPN annual net income has risen by +$20.44 million (+38.26%).
- SUPN annual net income is now -41.82% below its all-time high of $126.95 million, reached on December 31, 2020.
Performance
SUPN Net income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly net income:
-$11.83M-$27.16M(-177.16%)Summary
- As of today (May 29, 2025), SUPN quarterly net profit is -$11.83 million, with the most recent change of -$27.16 million (-177.16%) on March 31, 2025.
- Over the past year, SUPN quarterly net income has dropped by -$11.95 million (-9637.90%).
- SUPN quarterly net income is now -114.43% below its all-time high of $81.97 million, reached on December 31, 2011.
Performance
SUPN quarterly net income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM net income:
$61.91M-$11.95M(-16.18%)Summary
- As of today (May 29, 2025), SUPN TTM net profit is $61.91 million, with the most recent change of -$11.95 million (-16.18%) on March 31, 2025.
- Over the past year, SUPN TTM net income has increased by +$77.42 million (+499.24%).
- SUPN TTM net income is now -52.12% below its all-time high of $129.31 million, reached on September 30, 2020.
Performance
SUPN TTM net income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Net income Formula
Net Income = Revenue − COGS − Operating Expenses − Interest − Taxes − Other Expenses
SUPN Net income Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +5512.8% | -9637.9% | +499.2% |
| 3 y3 years | +38.3% | -146.2% | -15.6% |
| 5 y5 years | -34.7% | -155.0% | -46.7% |
SUPN Net income Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +5512.8% | -130.7% | +26.0% | -16.2% | +499.2% |
| 5 y | 5-year | -41.8% | +5512.8% | -129.6% | +26.0% | -52.1% | +499.2% |
| alltime | all time | -41.8% | +180.1% | -114.4% | +56.8% | -52.1% | +167.1% |
SUPN Net income History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | -$11.83M(-177.2%) | $61.91M(-16.2%) |
| Dec 2024 | $73.86M(+5512.8%) | $15.33M(-60.2%) | $73.86M(+23.7%) |
| Sep 2024 | - | $38.50M(+93.3%) | $59.71M(+1039.8%) |
| Jun 2024 | - | $19.92M(>+9900.0%) | $5.24M(-133.8%) |
| Mar 2024 | - | $124.00K(-89.4%) | -$15.51M(-1278.4%) |
| Dec 2023 | $1.32M(-97.8%) | $1.18M(-107.4%) | $1.32M(-94.9%) |
| Sep 2023 | - | -$15.98M(+1822.5%) | $25.62M(-40.9%) |
| Jun 2023 | - | -$831.00K(-104.9%) | $43.35M(-16.7%) |
| Mar 2023 | - | $16.95M(-33.5%) | $52.04M(-14.3%) |
| Dec 2022 | $60.71M(+13.6%) | $25.48M(+1356.9%) | $60.71M(+61.2%) |
| Sep 2022 | - | $1.75M(-77.8%) | $37.67M(-34.5%) |
| Jun 2022 | - | $7.87M(-69.3%) | $57.48M(-21.6%) |
| Mar 2022 | - | $25.62M(+949.0%) | $73.35M(+37.3%) |
| Dec 2021 | $53.42M(-57.9%) | $2.44M(-88.7%) | $53.42M(-34.6%) |
| Sep 2021 | - | $21.56M(-9.1%) | $81.75M(-18.4%) |
| Jun 2021 | - | $23.73M(+316.7%) | $100.19M(-9.8%) |
| Mar 2021 | - | $5.69M(-81.5%) | $111.13M(-12.5%) |
| Dec 2020 | $126.95M(+12.3%) | $30.77M(-23.1%) | $126.95M(-1.8%) |
| Sep 2020 | - | $40.00M(+15.4%) | $129.31M(+9.4%) |
| Jun 2020 | - | $34.67M(+61.1%) | $118.17M(+1.7%) |
| Mar 2020 | - | $21.52M(-35.0%) | $116.23M(+2.8%) |
| Dec 2019 | $113.06M(+1.9%) | $33.13M(+14.8%) | $113.06M(+6.8%) |
| Sep 2019 | - | $28.86M(-11.8%) | $105.82M(+0.8%) |
| Jun 2019 | - | $32.73M(+78.4%) | $104.97M(+1.9%) |
| Mar 2019 | - | $18.34M(-29.2%) | $102.98M(-7.2%) |
| Dec 2018 | $110.99M(+93.8%) | $25.89M(-7.6%) | $110.99M(+12.4%) |
| Sep 2018 | - | $28.01M(-8.9%) | $98.76M(+13.9%) |
| Jun 2018 | - | $30.74M(+16.6%) | $86.71M(+18.2%) |
| Mar 2018 | - | $26.35M(+92.9%) | $73.34M(+28.0%) |
| Dec 2017 | $57.28M | $13.66M(-14.4%) | $57.28M(-1.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2017 | - | $15.96M(-8.1%) | $57.95M(-44.2%) |
| Jun 2017 | - | $17.37M(+68.7%) | $103.81M(+7.4%) |
| Mar 2017 | - | $10.30M(-28.1%) | $96.69M(+6.0%) |
| Dec 2016 | $91.22M(+554.2%) | $14.32M(-76.8%) | $91.22M(+8.9%) |
| Sep 2016 | - | $61.83M(+503.1%) | $83.75M(+224.1%) |
| Jun 2016 | - | $10.25M(+112.5%) | $25.84M(+43.3%) |
| Mar 2016 | - | $4.83M(-29.6%) | $18.03M(+29.3%) |
| Dec 2015 | $13.94M(-227.6%) | $6.85M(+75.0%) | $13.94M(+28.2%) |
| Sep 2015 | - | $3.92M(+60.7%) | $10.88M(+136.9%) |
| Jun 2015 | - | $2.44M(+230.2%) | $4.59M(-14.3%) |
| Mar 2015 | - | $738.00K(-80.5%) | $5.36M(-149.0%) |
| Dec 2014 | -$10.93M(-88.2%) | $3.79M(-259.8%) | -$10.92M(-70.6%) |
| Sep 2014 | - | -$2.37M(-174.0%) | -$37.12M(-36.9%) |
| Jun 2014 | - | $3.20M(-120.6%) | -$58.84M(-34.2%) |
| Mar 2014 | - | -$15.54M(-30.6%) | -$89.40M(-3.1%) |
| Dec 2013 | -$92.27M(+99.4%) | -$22.41M(-7.0%) | -$92.27M(+10.7%) |
| Sep 2013 | - | -$24.10M(-11.9%) | -$83.38M(+14.6%) |
| Jun 2013 | - | -$27.36M(+48.6%) | -$72.77M(+31.3%) |
| Mar 2013 | - | -$18.41M(+36.3%) | -$55.42M(+19.7%) |
| Dec 2012 | -$46.28M(-186.0%) | -$13.51M(+0.2%) | -$46.28M(-194.1%) |
| Sep 2012 | - | -$13.48M(+34.6%) | $49.20M(-7.1%) |
| Jun 2012 | - | -$10.01M(+7.9%) | $52.95M(-4.7%) |
| Mar 2012 | - | -$9.28M(-111.3%) | $55.59M(+3.3%) |
| Dec 2011 | $53.81M(-239.9%) | $81.97M(-942.2%) | $53.81M(-246.5%) |
| Sep 2011 | - | -$9.73M(+32.0%) | -$36.73M(+36.1%) |
| Jun 2011 | - | -$7.38M(-33.2%) | -$27.00M(+37.6%) |
| Mar 2011 | - | -$11.05M(+28.9%) | -$19.62M(+128.9%) |
| Dec 2010 | -$38.46M(-8461.5%) | -$8.57M(+4.7%) | -$8.57M(+4.7%) |
| Dec 2009 | $460.00K(-101.4%) | -$8.19M | -$8.19M |
| Dec 2008 | -$33.48M(+93.8%) | - | - |
| Dec 2007 | -$17.27M | - | - |
FAQ
- What is Supernus Pharmaceuticals annual net profit?
- What is the all time high annual net income for Supernus Pharmaceuticals?
- What is Supernus Pharmaceuticals annual net income year-on-year change?
- What is Supernus Pharmaceuticals quarterly net profit?
- What is the all time high quarterly net income for Supernus Pharmaceuticals?
- What is Supernus Pharmaceuticals quarterly net income year-on-year change?
- What is Supernus Pharmaceuticals TTM net profit?
- What is the all time high TTM net income for Supernus Pharmaceuticals?
- What is Supernus Pharmaceuticals TTM net income year-on-year change?
What is Supernus Pharmaceuticals annual net profit?
The current annual net income of SUPN is $73.86M
What is the all time high annual net income for Supernus Pharmaceuticals?
Supernus Pharmaceuticals all-time high annual net profit is $126.95M
What is Supernus Pharmaceuticals annual net income year-on-year change?
Over the past year, SUPN annual net profit has changed by +$72.55M (+5512.84%)
What is Supernus Pharmaceuticals quarterly net profit?
The current quarterly net income of SUPN is -$11.83M
What is the all time high quarterly net income for Supernus Pharmaceuticals?
Supernus Pharmaceuticals all-time high quarterly net profit is $81.97M
What is Supernus Pharmaceuticals quarterly net income year-on-year change?
Over the past year, SUPN quarterly net profit has changed by -$11.95M (-9637.90%)
What is Supernus Pharmaceuticals TTM net profit?
The current TTM net income of SUPN is $61.91M
What is the all time high TTM net income for Supernus Pharmaceuticals?
Supernus Pharmaceuticals all-time high TTM net profit is $129.31M
What is Supernus Pharmaceuticals TTM net income year-on-year change?
Over the past year, SUPN TTM net profit has changed by +$77.42M (+499.24%)